GW&K Investment Management, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1082917
BOSTON, MA
Position in SUPN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$54,542,460
+$830,876 QoQ
Shares Held
1,055,184
-2.4% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 94.0651109190435.ToString("F0")%
Shared 5.894137894433578.ToString("F0")%
None 0.04075118652291923.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $163,730,959 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
593,725 | $78,217,331 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
1,055,184 | $54,542,460 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,240,462 | $30,849,197 | |
| 4 | VTRS |
Viatris Inc
|
2,967 | $40,084 | |
| 5 | HLN |
Haleon plc
|
3,869 | $38,728 | |
| 6 | ZTS |
Zoetis Inc.
|
208 | $24,587 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
580 | $10,741 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
260 | $7,831 |
All Filings in SUPN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,542,460 | 1,055,184 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $53,711,584 | 1,080,716 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $51,638,910 | 1,080,538 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,866,684 | 1,264,806 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $45,274,942 | 1,382,441 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $43,621,615 | 1,206,350 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $38,601,307 | 1,238,015 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $34,596,176 | 1,293,315 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $45,688,365 | 1,339,442 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $38,129,202 | 1,317,526 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $38,767,775 | 1,406,158 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $42,061,604 | 1,399,255 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $51,305,447 | 1,416,104 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $50,170,853 | 1,406,528 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $59,829,502 | 1,767,489 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $55,232,833 | 1,909,849 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $59,051,580 | 1,827,091 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $53,551,348 | 1,836,466 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $43,351,817 | 1,625,490 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $49,759,718 | 1,616,100 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $41,191,899 | 1,573,411 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $33,144,273 | 1,317,340 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $21,879,665 | 1,049,888 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $18,781,523 | 790,801 | Shares | Sole | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||